Antiviral Therapy for Patients With Liver Cancer After Surgery — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Antiviral Therapy for Patients With Liver Cancer After Surgery — Stella

Recruiting

Back to Hepatocellular Carcinoma trials

Trial locations(1 site)

China

Xiangya Hospital of Central South University, Changsha, Hunan

Key details

Sponsor

Xiangya Hospital of Central South University

Enrollment target

~360 participants

Started

December 2021

Primary completion

October 2027

Age range

18 Years – 65 Years

Last updated July 2022

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov